These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26542514)

  • 1. Amiodarone and risk of death in contemporary patients with atrial fibrillation: Findings from The Retrospective Evaluation and Assessment of Therapies in AF study.
    Ullal AJ; Than CT; Fan J; Schmitt S; Perino AC; Kaiser DW; Heidenreich PA; Frayne SM; Phibbs CS; Turakhia MP
    Am Heart J; 2015 Nov; 170(5):1033-1041.e1. PubMed ID: 26542514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study.
    Turakhia MP; Santangeli P; Winkelmayer WC; Xu X; Ullal AJ; Than CT; Schmitt S; Holmes TH; Frayne SM; Phibbs CS; Yang F; Hoang DD; Ho PM; Heidenreich PA
    J Am Coll Cardiol; 2014 Aug; 64(7):660-8. PubMed ID: 25125296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality risk of long-term amiodarone therapy for atrial fibrillation patients without structural heart disease.
    Qin D; Leef G; Alam MB; Rattan R; Munir MB; Patel D; Khattak F; Adelstein E; Jain SK; Saba S
    Cardiol J; 2015; 22(6):622-9. PubMed ID: 26412606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease.
    Piccini JP; Al-Khatib SM; Wojdyla DM; Shaw LK; Horton JR; Lokhnygina Y; Anstrom KJ; DeWald T; Allen-LaPointe N; Steinberg BA; Thomas K; Daubert JP; Peterson ED
    Am J Cardiol; 2014 Sep; 114(5):716-22. PubMed ID: 25129065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Effectiveness of Heart Rate Control Medications for the Treatment of Sepsis-Associated Atrial Fibrillation.
    Bosch NA; Rucci JM; Massaro JM; Winter MR; Quinn EK; Chon KH; McManus DD; Walkey AJ
    Chest; 2021 Apr; 159(4):1452-1459. PubMed ID: 33619010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone use is associated with increased risk of stroke in patients with nonvalvular atrial fibrillation: a nationwide population-based cohort study.
    Chen WC; Chen WC; Chen CY; Wu BR; Cheng WC; Lin KH; Hsia TC; Chen W; Chen CH; Muo CH; Liao WC; Li CH
    Medicine (Baltimore); 2015 May; 94(19):e849. PubMed ID: 25984674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of low-dose amiodarone on atrial fibrillation or flutter in Japanese patients with heart failure.
    Shiga T; Wakaumi M; Imai T; Suzuki T; Hosaka F; Yamada Y; Matsuda N; Shoda M; Sugiura R; Hagiwara N; Kasanuki H
    Circ J; 2002 Jun; 66(6):600-4. PubMed ID: 12074281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of amiodarone use and outcomes in clinical practice for atrial fibrillation.
    Pokorney SD; Holmes DN; Shrader P; Thomas L; Fonarow GC; Mahaffey KW; Gersh BJ; Kowey PR; Naccarelli GV; Freeman JV; Singer DE; Washam JB; Peterson ED; Piccini JP; Reiffel JA
    Am Heart J; 2020 Feb; 220():145-154. PubMed ID: 31812756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy and antiarrhythmic drugs in atrial fibrillation: impact on mortality.
    Chung R; Houghtaling PL; Tchou M; Niebauer MJ; Lindsay BD; Tchou PJ; Chung MK
    Pacing Clin Electrophysiol; 2014 Oct; 37(10):1338-48. PubMed ID: 24831860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practice Patterns and Outcomes of Treatments for Atrial Fibrillation During Sepsis: A Propensity-Matched Cohort Study.
    Walkey AJ; Evans SR; Winter MR; Benjamin EJ
    Chest; 2016 Jan; 149(1):74-83. PubMed ID: 26270396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.
    Saksena S; Slee A; Waldo AL; Freemantle N; Reynolds M; Rosenberg Y; Rathod S; Grant S; Thomas E; Wyse DG
    J Am Coll Cardiol; 2011 Nov; 58(19):1975-85. PubMed ID: 22032709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of digoxin use in atrial fibrillation and the risk of all-cause mortality in patients ≥65 years of age with versus without heart failure.
    Shah M; Avgil Tsadok M; Jackevicius CA; Essebag V; Behlouli H; Pilote L
    Am J Cardiol; 2014 Aug; 114(3):401-6. PubMed ID: 24950677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treating Specialty and Outcomes in Newly Diagnosed Atrial Fibrillation: From the TREAT-AF Study.
    Perino AC; Fan J; Schmitt SK; Askari M; Kaiser DW; Deshmukh A; Heidenreich PA; Swan C; Narayan SM; Wang PJ; Turakhia MP
    J Am Coll Cardiol; 2017 Jul; 70(1):78-86. PubMed ID: 28662810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.
    Cadrin-Tourigny J; Wyse DG; Roy D; Blondeau L; Levesque S; Talajic M; Andrade JG; Dubuc M; Thibault B; Guerra PG; Macle L; Rivard L; Khairy P
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1306-13. PubMed ID: 25181386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
    J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone and mortality among elderly patients with acute myocardial infarction with atrial fibrillation.
    Kilborn MJ; Rathore SS; Gersh BJ; Oetgen WJ; Solomon AJ
    Am Heart J; 2002 Dec; 144(6):1095-101. PubMed ID: 12486436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin-amiodarone Combination is Associated With Excess All-cause Mortality in Patients With Atrial Fibrillation.
    Chiang JY; Chen PC; Yang YH; Chang CH; Chu FY; Chen JJ; Wu CK; Hwang JJ; Chiang FT; Lin LY; Lin JL
    Sci Rep; 2020 Mar; 10(1):4101. PubMed ID: 32139765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between use of amiodarone for non-valvular atrial fibrillation and patient survival: from the prospective China Atrial Fibrillation Registry.
    Hou XX; He L; Du X; Wang GH; Dong JZ; Ma CS
    Chin Med J (Engl); 2020 Dec; 134(3):309-317. PubMed ID: 33273373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amiodarone treatment in atrial fibrillation and the risk of incident cancers: A nationwide observational study.
    Rasmussen PV; Dalgaard F; Hilmar Gislason G; Torp-Pedersen C; Piccini J; D'Souza M; Ruwald MH; Pallisgaard JL; Hansen ML
    Heart Rhythm; 2020 Apr; 17(4):560-566. PubMed ID: 31790830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States.
    Naccarelli GV; Johnston SS; Lin J; Patel PP; Schulman KL
    Clin Cardiol; 2010 May; 33(5):270-9. PubMed ID: 20513065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.